Advisor Group Holdings, Inc. Alnylam Pharmaceuticals, Inc. Transaction History

Advisor Group Holdings, Inc.

$42.2 Billion
Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 1,364 shares of ALNY stock, worth $324,591. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,364

Previous 1,190 14.62%

Holding current value

$324,591

Previous $289,000 29.76%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$233.81 - $287.01 $40,682 - $49,939	174 Added 14.62%	1,364 $375,000
Q2 2024 Aug 13, 2024	SELL	$143.31 - $247.0 $53,454 - $92,131	-373 Reduced 23.86%	1,190 $289,000
Q1 2024 May 10, 2024	SELL	$146.51 - $198.2 $297,708 - $402,742	-2,032 Reduced 56.52%	1,563 $233,000
Q4 2023 Feb 12, 2024	SELL	$151.41 - $196.57 $94,631 - $122,856	-625 Reduced 14.81%	3,595 $688,000
Q3 2023 Nov 13, 2023	BUY	$170.77 - $211.65 $31,080 - $38,520	182 Added 4.51%	4,220 $747,000
Q2 2023 Aug 10, 2023	BUY	$185.01 - $212.05 $52,542 - $60,222	284 Added 7.57%	4,038 $766,000
Q1 2023 May 12, 2023	SELL	$182.66 - $235.53 $420,300 - $541,954	-2,301 Reduced 38.0%	3,754 $752,000
Q4 2022 Feb 10, 2023	BUY	$185.53 - $241.31 $528,946 - $687,974	2,851 Added 88.98%	6,055 $1.44 Million
Q3 2022 Nov 14, 2022	SELL	$138.54 - $232.0 $229,145 - $383,728	-1,654 Reduced 34.05%	3,204 $641,000
Q2 2022 Aug 10, 2022	SELL	$120.42 - $169.29 $99,346 - $139,664	-825 Reduced 14.52%	4,858 $709,000
Q1 2022 May 04, 2022	BUY	$127.18 - $173.91 $32,176 - $43,999	253 Added 4.66%	5,683 $850,000
Q3 2021 Nov 05, 2021	BUY	$169.75 - $207.73 $44,474 - $54,425	262 Added 5.07%	5,430 $1.03 Million
Q2 2021 Aug 02, 2021	BUY	$128.63 - $176.89 $77,692 - $106,841	604 Added 13.23%	5,168 $876,000
Q1 2021 May 13, 2021	BUY	$126.83 - $175.69 $293,357 - $406,370	2,313 Added 102.75%	4,564 $643,000
Q4 2020 Feb 10, 2021	BUY	$122.97 - $147.0 $28,774 - $34,398	234 Added 11.6%	2,251 $292,000
Q3 2020 Nov 12, 2020	BUY	$121.19 - $165.49 $40,356 - $55,108	333 Added 19.77%	2,017 $292,000
Q2 2020 Aug 14, 2020	BUY	$104.21 - $156.44 $24,489 - $36,763	235 Added 16.22%	1,684 $247,000
Q1 2020 May 18, 2020	BUY	$93.12 - $133.99 $134,930 - $194,151	1,449 New	1,449 $159,000

Others Institutions Holding ALNY

# of Institutions

643

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $29.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Alnylam Pharmaceuticals, Inc. Transaction History